Tradestie Institutional Equity Comparison Engine

UNOV vs SNY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNY Overall Edge

SNY Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) driven by superior Valuation, Growth & Margin, Options & Structure while UNOV counters with relative strength in Momentum & Technical. Fundamentally, UNOV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SNY at 8.9x Forward P/E and 22.3% operating margin (+15.7% YoY). In options structure, UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNY sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNY
UNOV N/M vs SNY 8.9x Fwd P/E
Growth & Margin Winner SNY
Op Margin N/A vs 22.3% ยท YoY N/A vs +15.7%
Momentum & Technical Winner UNOV
1Y +9.5% vs -7.5% ยท 52W Pos 84% vs 68%
Options & Structure Winner SNY
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (43rd %ile IV)
UNOV Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap N/A
1M Return -0.97%
1Y Return +9.53%
Forward P/E N/M
Unified AI Score
58.7 / 100 HOLD
Tech 48.0 Fund 60.0 Flow 50.0 Mom 50.0
SNY NASDAQ
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Pharmaceutical Preparations
$48.39
+0.04% 1D
Market Cap $116.1B
1M Return +19.16%
1Y Return -7.55%
Forward P/E 8.9x
Unified AI Score
31.7 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UNOV +9.53% SNY -7.55% Spread: +17.08 pp (UNOV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UNOV TTM Op. Margin: N/A SNY TTM Op. Margin: 22.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UNOV vs SNY. Trailing 12-month operating profitability (UNOV N/A vs SNY 22.3%) and valuation multiples (UNOV N/M vs SNY 8.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UNOV (3) vs SNY (7)
Institutional Metric UNOV SNY Criterion Row Winner
Market Capitalization Scale N/A $116.1B Larger Scale SNY
Trailing P/E Ratio Valuation N/M 24.1x Lower Multiple SNY
Forward P/E Ratio Valuation N/M 8.9x Lower Multiple SNY
Revenue Growth (YoY) Growth N/A +15.7% Higher Growth SNY
Operating Margin (TTM) Profitability N/A 22.3% Higher Margin SNY
Net Profit Margin Profitability N/A 8.2% Higher Margin SNY
Return on Equity (ROE) Capital Efficiency N/A 5.7% Higher ROE SNY
52-Week Range Position Momentum 84% ($37โ€“$42) 68% ($39โ€“$53) Stronger Trend UNOV
Beta / 30D Volatility Risk Regime 0.46ฮฒ ยท 11% Vol 0.21ฮฒ ยท 27% Vol Lower Realized Risk UNOV
Unified Institutional Score Composite Signal 58.7 / 100 (HOLD) 31.7 / 100 (SELL) Higher Composite UNOV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UNOV vs SNY Buy Guide
UNOV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UNOV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SNY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UNOV nor SNY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.